Moscow, 20 January 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces European Union Good Manufacturing Practice (EU GMP) certifications obtainment for 6 production lines of JSC «Pharmstandard-Leksredstva». Latvian State Medicines Agency during its prior inspection confirmed that products are consistently produced and controlled to the quality standards appropriate to their intended use according to GMP guidelines.

GMP certificates obtainment is the result of company’s continuous work (started in 2005) for the product lines certification. At present, 6 production lines (65% of the total production capacity) of JSC «Pharmstandard-Leksredstva» meet GMP requirements. In 2008 the company produced 160 million packs of tablets, capsules, sachets, sprays, syrups and suspensions on the certified lines.

Igor Krylov, CEO of JSC “Pharmstandard” commented:

«EU GMP certifications obtainment for JSC «Pharmstandard-Leksredstva» is the result of longstanding, labour-intensive efforts of our employees, capital expenditures in new production lines construction and launching. JSC «Pharmstandard-Leksredstva» is the first Russian pharmaceutical plant included in EudraGMP database».

For additional information about EU GMP, and EudraGMP please use the following link:

https://www.emea.europa.eu/Inspections/GMPhome.html